Format

Send to

Choose Destination
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):2868-73. doi: 10.1073/pnas.1520244113. Epub 2016 Feb 29.

Efficient delivery of genome-editing proteins using bioreducible lipid nanoparticles.

Author information

1
Department of Biomedical Engineering, Tufts University, Medford, MA 02155;
2
Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138; Howard Hughes Medical Institute, Harvard University, Cambridge, MA 02138;
3
Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030.
4
Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA 02138; Howard Hughes Medical Institute, Harvard University, Cambridge, MA 02138; drliu@fas.harvard.edu qiaobing.xu@tufts.edu.
5
Department of Biomedical Engineering, Tufts University, Medford, MA 02155; drliu@fas.harvard.edu qiaobing.xu@tufts.edu.

Abstract

A central challenge to the development of protein-based therapeutics is the inefficiency of delivery of protein cargo across the mammalian cell membrane, including escape from endosomes. Here we report that combining bioreducible lipid nanoparticles with negatively supercharged Cre recombinase or anionic Cas9:single-guide (sg)RNA complexes drives the electrostatic assembly of nanoparticles that mediate potent protein delivery and genome editing. These bioreducible lipids efficiently deliver protein cargo into cells, facilitate the escape of protein from endosomes in response to the reductive intracellular environment, and direct protein to its intracellular target sites. The delivery of supercharged Cre protein and Cas9:sgRNA complexed with bioreducible lipids into cultured human cells enables gene recombination and genome editing with efficiencies greater than 70%. In addition, we demonstrate that these lipids are effective for functional protein delivery into mouse brain for gene recombination in vivo. Therefore, the integration of this bioreducible lipid platform with protein engineering has the potential to advance the therapeutic relevance of protein-based genome editing.

KEYWORDS:

CRISPR/Cas9; Cre recombinase; genome editing; lipid nanoparticle; protein delivery

PMID:
26929348
PMCID:
PMC4801296
DOI:
10.1073/pnas.1520244113
[Indexed for MEDLINE]
Free PMC Article

Publication types, MeSH terms, Substances, Grant support

Publication types

MeSH terms

Substances

Grant support

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center